Strides Pharma Science Ltd - 532531 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

Strides Pharma Science Ltd.

NSE: STAR | BSE: 532531 | ISIN: INE939A01011 | Industry: Pharmaceuticals
| Strong Performer, Under Radar

882.4500 28.35 (3.32%)

NSE Jun 13, 2025 15:31 PM

47.32% Fall from 52W High

Volume: 737.7K

Strides Pharma Science Ltd.

06 Sep 2024

882.45

3.32%

Company Update

Strides Pharma Science Ltd - 532531 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

BSE India

Strides receive USFDA approval for Theophylline Extended-Release Tablets, 300mg and 450mg

More from Strides Pharma Science Ltd.

Recommended

Five Interesting Stocks Today - June 13, 2025

The Baseline | 13 Jun 2025

Market closes lower, NCLT admits IREDA’s insolvency plea against Gensol Engineering

Trendlyne Marketwatch | 13 Jun 2025

Earnings Call Transcript - Q1FY21 for Strides Pharma Science